Goldman Sachs Group Inc Jazz Pharmaceuticals PLC Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 145,072 shares of JAZZ stock, worth $17.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,072
Previous 189,969 23.63%
Holding current value
$17.6 Million
Previous $20.3 Million 20.25%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.57 - $116.37 $4.52 Million - $5.22 Million
-44,897 Reduced 23.63%
145,072 $16.2 Million
Q2 2024

Aug 13, 2024
BUY
$103.94 - $118.98 $374,703 - $428,922
3,605 Added 1.93%
189,969 $20.3 Million
Q1 2024

May 15, 2024
SELL
$115.19 - $132.77 $6.01 Million - $6.93 Million
-52,158 Reduced 21.87%
186,364 $22.4 Million
Q4 2023

Feb 13, 2024
SELL
$114.26 - $136.0 $7.29 Million - $8.67 Million
-63,772 Reduced 21.1%
238,522 $29.3 Million
Q3 2023

May 14, 2024
BUY
$122.0 - $145.31 $7.78 Million - $9.27 Million
63,772 Added 26.74%
302,294 $39.1 Million
Q3 2023

Nov 14, 2023
BUY
$122.0 - $145.31 $3.4 Million - $4.05 Million
27,895 Added 10.17%
302,294 $39.1 Million
Q2 2023

May 14, 2024
BUY
$122.5 - $147.16 $101,675 - $122,142
830 Added 0.3%
274,399 $34 Million
Q2 2023

Aug 14, 2023
BUY
$122.5 - $147.16 $101,675 - $122,142
830 Added 0.3%
274,399 $34 Million
Q1 2023

May 14, 2024
SELL
$133.98 - $160.47 $22.8 Million - $27.3 Million
-170,418 Reduced 38.38%
273,569 $40 Million
Q1 2023

May 11, 2023
SELL
$133.98 - $160.47 $22.8 Million - $27.3 Million
-170,418 Reduced 38.38%
273,569 $40 Million
Q4 2022

May 14, 2024
SELL
$129.72 - $159.85 $41.9 Million - $51.7 Million
-323,146 Reduced 42.12%
443,987 $70.7 Million
Q4 2022

Feb 13, 2023
SELL
$129.72 - $159.85 $41.9 Million - $51.7 Million
-323,146 Reduced 42.12%
443,987 $70.7 Million
Q3 2022

May 14, 2024
SELL
$126.59 - $161.18 $26 Million - $33.1 Million
-205,248 Reduced 21.11%
767,133 $102 Million
Q3 2022

Nov 10, 2022
SELL
$126.59 - $161.18 $26 Million - $33.1 Million
-205,248 Reduced 21.11%
767,133 $102 Million
Q2 2022

May 14, 2024
BUY
$141.59 - $168.66 $104 Million - $124 Million
733,859 Added 307.67%
972,381 $152 Million
Q2 2022

Aug 15, 2022
SELL
$141.59 - $168.66 $12.7 Million - $15.2 Million
-89,848 Reduced 8.46%
972,381 $152 Million
Q1 2022

May 16, 2022
SELL
$129.64 - $160.7 $32.2 Million - $39.9 Million
-248,500 Reduced 18.96%
1,062,229 $165 Million
Q4 2021

Feb 14, 2022
BUY
$119.87 - $145.67 $136 Million - $165 Million
1,133,121 Added 637.99%
1,310,729 $167 Million
Q3 2021

Nov 10, 2021
BUY
$128.64 - $184.79 $22.8 Million - $32.8 Million
177,608 New
177,608 $23.1 Million

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.6B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email